Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycine transporter type 1 (GlyT1) is a sodium- and chloride-dependent membrane protein responsible for the reuptake of glycine from the synaptic cleft, primarily in the central nervous system. GlyT1 plays a crucial role in regulating extracellular glycine concentrations, which directly impacts neurotransmission and NMDA receptor function. It is a therapeutic target for schizophrenia, cognitive disorders, and other neurological conditions.
Inhibition of GlyT1 increases extracellular synaptic glycine levels, potentiating NMDA receptor activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine transporter type 1 (GlyT1).